home / stock / xgn / xgn news

XGN News and Press, Exagen Inc. From 08/03/20

Stock Information
Company Name: Exagen Inc.
Stock Symbol: XGN
Market: NYSE
Website: exagen.com
Menu
XGN XGN Quote XGN Short XGN News XGN Articles XGN Message Board
Get XGN Alerts

News, Short Squeeze, Breakout and More Instantly...
XGN - Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid Syndrome

SAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today a collaboration with Hospital for Special Surgery (HSS) in New York City. This well...
XGN - Exagen to Present at the Canaccord Genuity 40th Annual Growth Conference

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that Ron Rocca, President and Chief Executive Officer of Exagen, will present at the Can...

XGN - Exagen Inc. (XGN) CEO Ron Rocca on Q2 2020 Results - Earnings Call Transcript

Exagen Inc. (XGN) Q2 2020 Earnings Conference Call July 28, 2020 at 08.00 ET Company Participants Ron Rocca - President and Chief Executive Officer Kamal Adawi - Chief Financial Officer Mark Hazeltine - Senior Vice President of Finance & Corporate Development Conference Ca...

XGN - Exagen Inc. (XGN) Q2 2020 Earnings Call Transcript

Image source: The Motley Fool. Exagen Inc.   (NASDAQ: XGN) Q2 2020 Earnings Call Jul 28, 2020 , 8:00 a.m. ET Operator Continue reading

XGN - Exagen EPS beats by $0.49, beats on revenue

Exagen (NASDAQ: XGN ) : Q2 GAAP EPS of -$0.27 beats by $0.49 . More news on: Exagen Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

XGN - Exagen Inc. Reports Second Quarter 2020 Results

Testing Experiencing Monthly Sequential Improvement Record Gross Margins of 63% SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today reported...

XGN - Exagen Inc. AVISE Testing Now Covered and In-Network with TRICARE East

SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that all AVISE test offerings (CTD, Lupus, SLE Prognostic, SLE Monitor, APS, MTX and HCQ) wil...
XGN - Exagen to Announce Second Quarter Financial Results on July 28, 2020

SAN DIEGO, July 16, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that it will release financial results for the quarter ended June 30, 2020 before t...

XGN - Exagen and the Ohio State Innovation Foundation Announce Exclusive License Agreement and Research Collaboration for a Novel, Rule-In, Blood Test to Support the Diagnosis of Fibromyalgia

SAN DIEGO, June 17, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced it has entered into an exclusive worldwide license agreement with the Ohio State In...

XGN - Exagen Inc. Announces Clinical Trial Conducted at Major Academic Center in Distinguishing Type 1 and Type 2 Lupus

SAN DIEGO, June 03, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today a clinical trial in collaboration with Duke University in Durham, NC. The Duke Lupu...
Previous 10 Next 10